Blood Cancer
Showing 1–16 of 72 results
-
ADAKVEO (crizanlizumab-tmca) injection, for intravenous use. Initial U.S. Approval: 2019
Read more -
ALIQOPA (copanlisib) for injection, for intravenous use.
Read more -
ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection.
Read more -
APHEXDA (motixafortide)
Read more -
Atriance (nelarabine) for injection
Read more -
BIMZELX (bimekizumab-bkzx) injection
Read more -
BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use.
Read more -
BLINCYTO (blinatumomab) for injection, for intravenous use. Initial U.S. Approval: 2014
Read more -
BOSULIF (bosutinib) tablets
Read more -
BRUKINSA (zanubrutinib) capsules, for oral use.
Read more -
CABLIVI (caplacizumab-yhdp) for injection
Read more -
CALQUENCE (acalabrutinib) capsules, for oral use.
Read more -
Columvi (glofitamab) for injection
Read more -
COPIKTRA (duvelisib), capsules for oral use.
Read more -
COTELLIC (cobimetinib) tablets. FDA-Approved
Read more -
DARZALEX (daratumumab) injection, for intravenous use.
Read more
